相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55-induced EAE through ERK and Akt signalling
Salar Kamali et al.
BRAIN PATHOLOGY (2021)
Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE
Anje Cauwels et al.
SCIENTIFIC REPORTS (2021)
FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models
Ranjithkumar Rajendran et al.
CELLS (2021)
Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE
Ranjithkumar Rajendran et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Brain-derived neurotrophic factor in autoimmune inflammatory diseases (Review)
Ningning Wang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes
Ranjithkumar Rajendran et al.
CELLS (2021)
Noninvasive Brain Delivery and Efficacy of BDNF to Stimulate Neuroregeneration and Suppression of Disease Relapse in EAE Mice
Brian M. Kopec et al.
MOLECULAR PHARMACEUTICS (2020)
Treatment of Multiple Sclerosis: A Review
Stephen L. Hauser et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Antagonism of interferon signaling by fibroblast growth factors promotes viral replication
Luigi Maddaluno et al.
EMBO MOLECULAR MEDICINE (2020)
Fibroblast Growth Factor 2 Enhances Zika Virus Infection in Human Fetal Brain
Daniel Limonta et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential
Katja Thummler et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation
Ranjithkumar Rajendran et al.
BRAIN PATHOLOGY (2018)
Regenerating CNS myelin - from mechanisms to experimental medicines
Robin J. M. Franklin et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9
Maren Lindner et al.
BRAIN (2015)
Fibroblast Growth Factor Signaling in Oligodendrocyte-Lineage Cells Facilitates Recovery of Chronically Demyelinated Lesions But Is Redundant in Acute Lesions
Miki Furusho et al.
GLIA (2015)
Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities
Masoud Mehrpour et al.
NEUROLOGIST (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Role of ERK1/2 MAPK Signaling in the Maintenance of Myelin and Axonal Integrity in the Adult CNS
Akihiro Ishii et al.
JOURNAL OF NEUROSCIENCE (2014)
Immunomodulatory activity of interferon-beta
Lloyd H. Kasper et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination
Hema Mohan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Immune response during interferon beta-1b treatment in patients with multiple sclerosis who experienced relapses and those who were relapse-free in the START study
Suhayl Dhib-Jalbut et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Therapies for multiple sclerosis: translational achievements and outstanding needs
Aiden Haghikia et al.
TRENDS IN MOLECULAR MEDICINE (2013)
The Mechanism of Action of Interferon-beta in Relapsing Multiple Sclerosis
Bernd C. Kieseier
CNS DRUGS (2011)
Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis
Andrea Rottlaender et al.
IMMUNOLOGY (2011)
FGF-2 and Anosmin-1 Are Selectively Expressed in Different Types of Multiple Sclerosis Lesions
Diego Clemente et al.
JOURNAL OF NEUROSCIENCE (2011)
Interferon-β therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism
David Azoulay et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection
David Azoulay et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Constitutively active Akt induces enhanced myelination in the CNS
Ana I. Flores et al.
JOURNAL OF NEUROSCIENCE (2008)
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients
Paola Sarchielli et al.
NEUROSCIENCE LETTERS (2008)
LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis
Sha Mi et al.
NATURE MEDICINE (2007)
Interferon-β regulates cytokines and BDNF:: greater effect in relapsing than in progressive multiple sclerosis
K. Hamomcioglu et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy
M Caggiula et al.
CLINICAL IMMUNOLOGY (2006)
Complex modulation of cell type-specific signaling in response to type I Interferons
Anette H. H. van Boxel-Dezaire et al.
IMMUNITY (2006)
Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways
RD Almeida et al.
CELL DEATH AND DIFFERENTIATION (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier
F Wang et al.
NATURE IMMUNOLOGY (2004)
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice
F Ruffini et al.
GENE THERAPY (2001)
KGF alters gene expression in human airway epithelia: potential regulation of the inflammatory response
LS Prince et al.
PHYSIOLOGICAL GENOMICS (2001)
分享论文
